Linguistic Deficiencies in Primary Progressive Multiple Sclerosis
The aim of the present study is to investigate the linguistic profile
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
The aim of the present study is to investigate the linguistic profile
reaction rubor, six AN animal model of disseminated multiple sclerosis (MS), and later investigated in 2 clinical trial clinical trials for relapsingremitting (RR)MS. seven In these trials, fingolimod
GilenyaÃ?®, Novartis Pharma AG) is a sphingosine 1-phosphate receptor modulator approved for relapsing MS treatment. Continuous collection and analysis of real world effectiveness and safety data ... objective is to…
Background: Fingolimod is a new orally available compound for the treatment of
Background: Many patients with relapsing-remitting MS (RRMS) show a suboptimal response
Multiple Sclerosis (MS) is a relapsing or progressive neurological disease with an unknown etiology. MS has a negative impact on both physical and psychological well being. One of the most ... study took place in Sofia…
Multiple Sclerosis (MS) is a relapsing or progressive neurological disease with an unknown etiology. MS has a negative impact on both physical and psychological well being. One of the most ... study took place in Sofia…
No single environmental exposure has been consistently identified as a causal factor
exact mechanisms underlying neuroinflammation and neuropathology in multiple sclerosis (MS) are still unknown, but susceptibility depends on a combination of genetic and environmental risk factors and their…
Multiple sclerosis (MS) is the most important immune-mediated demyelinated disease of human which is typically the disease of young adults. A total of 4% to 5% of MS population ... pediatric. Pediatric MS is defined as…
Fingolimod is the first orally bioavailable disease modifying agent approved for the management of relapsingremitting multiple sclerosis (RRMS). Even though it is generally well tolerated, it requires a specific…
Multiple sclerosis (MS) is a socially important disease, with a high level of acquired disability in a relatively young population. Motor weakness, spasticity, balance and coordination dysfunctions provoke severe…
multiple sclerosis (MS) treatment. Recently, the rationale of evolution from myeloablative to non-myeloablative (NM) transplant regimens has been discussed. We aimed to study clinical outcomes in MS patients after…
For authors and organisers
Find the right journal for your paper and submit your manuscript.